SYNERGY-AI Cancer Trial Finder 2.8

SYNERGY-AI Cancer Clinical Trial Finder provides cancer patients with access to new and personalized treatment options that are undergoing FDA approvals, eliminating the need for long waiting times for suitable cancer treatment trials. The platform can identify clinical trials based on specific criteria such as location, cancer stage, type, biomarker status, and other relevant data points.

Utilizing an Artificial Intelligence (AI) engine in conjunction with a comprehensive approach involving expert oncologists, the platform matches individual characteristics and cancer genomics with thousands of ongoing clinical trials. This enables real-time identification and notification of eligibility for enrollment. SYNERGY-AI is distinguished as the sole entity employing an AI-integrated application and mobile technology to determine clinical trial eligibility and identify optimal sites in close proximity.

Massive Bio delivers a unique, personalized, evidence-based service designed to simplify the journey for cancer patients. The emphasis is on providing support so that no individual has to combat cancer on their own.

Users receive notifications for matching clinical trials in proximity to their zip code, along with other pertinent cancer-related information to aid in their battle against cancer.

Physicians evaluate clinical trials and recommend patients for enrollment using Synergy AI.